BofA Upgrades Microchip to Buy, Sees More Upside Ahead
BofA analyst upgrades Microchip to Buy, raises price target to $95, citing inventory recovery, growth markets, and higher earnings forecasts.
BofA analyst upgrades Microchip to Buy, raises price target to $95, citing inventory recovery, growth markets, and higher earnings forecasts.
Qorvo stock drops 11% premarket after issuing weaker-than-expected Q4 guidance, despite beating revenue and earnings estimates in Q3.
Seagate Technology (STX) beats Q2 expectations and forecasts strong Q3 growth as AI demand drives data storage needs. Stock hits new highs with 35% YTD gains.
Altimmune raises $75 million through registered direct offering to fund Phase 3 trial of pemvidutide for MASH treatment and advance its liver disease therapy pipeline.
ASML announces 1,700 job cuts to streamline operations while reporting record €13.2B Q4 bookings driven by AI chip demand. Sales expected to grow to €34-39B in 2026.
F5 (FFIV) exceeded expectations with 7% Q1 revenue growth and raised annual forecasts despite October security breach. Stock surged 14% after hours on strong results.